IL17A and colitis: These data indicate that IL-17A+ ILC, which could be ILC3 or inflammatory ILC2 (41), can drive colitis in the absence of T-bet and adaptive immune responses, such as regulatory T cells and sIgA, sIgM, and sIgG production.